课题基金 / 基金详情

The role of common genetic variation in the Fas pathway in acute lung injury

The role of common genetic variation in the Fas pathway in acute lung injury
Fas通路常见遗传变异在急性肺损伤中的作用
批准号:
8001682
负责人:
Bradford Joseph Glavan
金额:
$5.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-02 至 2011-08-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):危重患者发生急性肺损伤(ALI)有几个明确定义的危险因素,包括败血症、肺炎和创伤。然而,对于改变ALI易感性和相关不良结果(如多器官系统衰竭和死亡)的因素,人们仍然不完全了解。越来越多的文献表明,炎症和凋亡通路的失调在ALI的发展过程中。特别是,已知Fas/FasL通路是免疫反应的重要调节剂,与ALI患者肺部观察到的炎症和肺泡上皮细胞凋亡有关。动物研究表明,肺中Fas/FasL通路的激活可导致早期炎症、肺泡上皮细胞凋亡和纤维化,人体研究表明,ALI患者的不良结局与血浆和支气管肺泡灌洗液中可溶性FasL水平升高有关。这些发现表明,影响Fas/FasL系统功能的遗传变异可能影响ALI的易感性和相关死亡率。本建议的目的是:1)研究危重患者Fas/FasL通路常见遗传变异与ALI易感性之间的关系;2)确定Fas/FasL通路遗传多态性对ALI患者血浆中基因产物和炎症标志物水平的影响;3)确定体外Fas刺激后外周单核细胞Fas/FasL通路遗传变异的功能意义。急性肺损伤是一种严重肺功能障碍综合征,约7%的重症监护病房入院患者因急性肺损伤而复杂化,美国每年有74,000人死亡。对急性脑损伤的病因了解甚少,阻碍了有效治疗方法的发展。更好地了解Fas/FasL通路(调节细胞死亡和炎症)中常见遗传变异对急性脑损伤发展的影响,将为急性脑损伤的因果机制提供重要信息,并可能导致急性脑损伤的新疗法。
英文摘要
DESCRIPTION (provided by applicant): There are several clearly defined risk factors for the development of acute lung injury (ALI) in critically ill patients including sepsis, pneumonia and trauma. However, there remains incomplete understanding regarding the factors that alter susceptibility to the development of ALI and related poor outcomes such as multi-organ system failure and death. A growing body of literature implicates the dysregulation of inflammation and apoptotic pathways in the development of ALI. In particular, the Fas/FasL pathway, known to be an important modulator of the immune response, has been implicated in the inflammation and alveolar epithelial cell apoptosis observed in the lungs of patients with ALI. Animal studies have demonstrated that activation of the Fas/FasL pathway in the lung leads to early inflammation, alveolar epithelial apoptosis and fibrosis and human studies have shown that adverse outcomes in patients with ALI are associated with increased plasma and bronchoalveolar lavage fluid levels of soluble FasL. These findings suggest that genetic variation affecting the function of the Fas/FasL system could influence susceptibility to ALI and related mortality. The aims of this proposal are to: 1) characterize associations between common genetic variation in the Fas/Fas ligand (FasL) pathway and susceptibility to ALI in a cohort of critically ill patients, 2) determine the effect of genetic polymorphisms in the Fas/FasL pathway on the plasma levels of gene products and markers of inflammation in patients with ALI, and 3) determine the functional significance of genetic variants in the Fas/FasL pathway in peripheral monocytes after Fas stimulation in vitro. Acute Lung Injury is a syndrome of severe lung dysfunction which complicates approximately 7% of intensive care unit admissions and accounts for 74,000 deaths annually in the US. The causes of ALI remain poorly understood, preventing the development of effective therapies. A better understanding of the impact of common genetic variation in the Fas/FasL pathway, which regulates cell death and inflammation, on the development of ALI would provide important information regarding causal mechanisms of ALI and could lead to new therapies for ALI. PUBLIC HEALTH RELEVANCE: Acute lung injury (ALI) is a syndrome of severe lung dysfunction which complicates approximately 7% of intensive care unit admissions and accounts for 74,000 deaths annually in the US. The causes of ALI remain poorly understood, preventing the development of effective therapies. A better understanding of the impact of common genetic variation in the Fas/FasL pathway, which regulates cell death and inflammation, on the development of ALI would provide important information regarding causal mechanisms of ALI and could lead to new therapies for ALI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金